Consensus Nuvei Corporation Toronto S.E.

Equities

NVEI

CA67079A1021

Real-time Estimate Cboe BZX 10:26:18 2024-04-26 am EDT 5-day change 1st Jan Change
32.24 USD 0.00% Intraday chart for Nuvei Corporation -2.34% +108.19%

Evolution of the average Target Price on Nuvei Corporation

Price target over the last 5 years

History of analyst recommendation changes

d65b0c97c8086c75f79e2c466.uG1GV_mBDoDx71FCD4W__mgnw8AqrWv8AV3kd5zTavU.j1UNI5O1bcmJ2T8JOuLGlV5l8PJhzDKGRSytPf2YGp6KLyMmldc4ssPXCA~8a4693a86e6096f6d86fe7287e29dc55
UBS on Nuvei Going Private Transaction MT
Citigroup Raises Nuvei's Price Target to $34 From $23, Maintains Neutral Rating MT
UBS Downgrades Nuvei to Neutral From Buy, Raises Price Target to $34 From $30 MT
Keefe Bruyette & Woods Downgrades Nuvei to Market Perform From Outperform, Adjusts PT to $34 From $31 MT
Seaport Global Downgrades Nuvei to Neutral From Buy MT
Wolfe Research Downgrades Nuvei to Peer Perform From Outperform MT
News Highlights : Top Company News of the Day - Monday at 11 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 7 PM ET DJ
William Blair Downgrades Nuvei to Market Perform From Outperform MT
Barclays Adjusts Price Target on Nuvei to $32 From $34, Maintains Overweight Rating MT
UBS Raises Nuvei Price Target to $30 From $24, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Nuvei to $27 From $29, Maintains Equalweight Rating MT
RBC Raises Price Target on Nuvei to $34 From $29, Keeps Outperform Rating MT
Wells Fargo Starts Nuvei With Equalweight Rating, $29 Price Target MT
Goldman Sachs Adjusts Price Target on Nuvei to $30 From $21, Maintains Neutral Rating MT
Barclays Initiates Nuvei at Overweight Rating With $34 Price Target MT
Nuvei Maintained at Outperform at BMO Following Analyst Switch; Price Target Kept at US$30.00 MT
Moody's, S&P Rate Nuvei's Proposed Senior Secured Credit Facilities MT
Seaport Initiates Coverage of Nuvei Corp With Buy Rating, US$25 Target MT
Seaport Initiates Nuvei at Buy With $25 Price Target, Cites 'Intriguing Growth Profile at Reasonable Valuation' MT
Goldman Sachs Adjusts Nuvei's Price Target to $21 From $19, Maintains Neutral Rating MT
UBS Adjusts Nuvei Price Target to $24 From $20, Maintains Buy Rating MT
Financials Advance as Rate Fears Subside -- Financials Roundup DJ
UBS Initiates Coverage on Nuvei With Buy Rating, $20 Price Target MT
Raymond James Trims Price Target on Nuvei to $27 From $28, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
32.13 USD
Average target price
27.31 USD
Spread / Average Target
-15.02%
High Price Target
34.62 USD
Spread / Highest target
+7.72%
Low Price Target
20 USD
Spread / Lowest Target
-37.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nuvei Corporation

Citigroup
UBS
Keefe, Bruyette & Woods
Seaport Global Securities
Wolfe Research
William Blair & Co.
Barclays
RBC Capital Markets
Wells Fargo Securities
Goldman Sachs
BMO Capital
Raymond James
Canaccord Genuity
Credit Suisse
JPMorgan Chase
SMBC Nikko
WestPark Capital
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings